Angiomax 250 mg (Bivalirudin POWDER FOR SOLUTION) 250 MG

Angiomax 250 mg is a powder for solution used for intravenous administration. It contains bivalirudin, a medication often associated with anticoagulant properties. This product is manufactured by Sandoz Canada Incorporated.

Strength

250 MG

Pack Size

10X5ML

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Angiomax 250 mg is generally used in medical settings where anticoagulation is required. It is often utilized during procedures such as percutaneous coronary intervention (PCI) to prevent blood clots. The primary active ingredient, bivalirudin, works by inhibiting certain processes in the blood. Patients should consult their healthcare provider to understand what Angiomax is used for in their specific situation.

Side Effects

Common effects of Angiomax 250 mg may include bleeding at the injection site or other areas of the body. Some individuals might experience bruising, nausea, or dizziness. These effects can vary from person to person and are not exhaustive. Always seek medical advice if you have concerns about any effects experienced while using this medication.

Precautions & Warnings

Angiomax 250 mg should be handled with care, as it is intended for intravenous use only. It is important to follow proper administration procedures to avoid complications. Patients with a history of bleeding disorders or allergies to bivalirudin should exercise caution. Always store and use this medication as directed by a healthcare professional.

Avoid Interactions

Angiomax 250 mg may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods might also interact with this medication, so it is advisable to discuss any potential interactions with a medical professional.

References

Frequently Asked Questions

Angiomax 250 mg is typically used for anticoagulation during medical procedures like PCI to prevent blood clots.

Angiomax 250 mg is administered intravenously as a solution prepared from the powder.

Common effects may include bleeding at the injection site, bruising, nausea, or dizziness.

Angiomax 250 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Patients with a history of bleeding disorders or allergies to bivalirudin should exercise caution when using Angiomax 250 mg.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.